Publications by authors named "Zoe Garrett"

Claim this Profile
E
European collaboration on health technology assessment: looking backward and forward.
Alric Ruether, Iñaki Imaz-Iglesia, Chantal Bélorgey, Alessandra Lo Scalzo, Zoe Garrett

Int J Technol Assess Health Care· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Building a model of health technology assessment cooperation: lessons learned from EUnetHTA joint action 3.
Zoe Garrett, Iñaki Imaz-Iglesia, Anne Willemsen

Int J Technol Assess Health Care· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The fourth edition of the European Network for Health Technology Assessment Forum: highlights and outcomes.
Giovanni Tafuri, Chantal Bélorgey, Carlo Favaretti, Edith Frénoy, Flora Giorgio, Zoe Garrett

Int J Technol Assess Health Care· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EVIDENCE REQUIREMENTS FOR REIMBURSEMENT OF PHARMACEUTICALS ACROSS EUROPE.
Oyinlola Oyebode, Zoe Garrett, Elizabeth George, Agnese Cangini, Luisa Anna Adele Muscolo

Int J Technol Assess Health Care· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NICE guidance on everolimus in combination with exemestane for treatment of advanced HER2-negative, hormone-receptor-positive breast cancer after endocrine therapy.
Martyn J Burke, Zoe Garrett, Elisabeth George, Amanda I Adler

Lancet Oncol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NICE guidance on denosumab for prevention of skeletal-related events in adults with bone metastases from solid tumours.
Anwar Jilani, Zoe Garrett, Frances Sutcliffe, Andrew Stevens

Lancet Oncol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NICE guidance on rituximab for first-line treatment of symptomatic stage III-IV follicular lymphoma in previously untreated patients.
Sally Doss, Zoe Garrett, Frances Sutcliffe, Andrew Stevens

Lancet Oncol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NICE guidance on trastuzumab for the treatment of HER2-positive metastatic gastric cancer.
Joanne Holden, Zoe Garrett, Andrew Stevens

Lancet Oncol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic reviews and their application to research in speech and language therapy: a response to T. R. Pring's 'Ask a silly question: two decades of troublesome trials' (2004).
Zoe Garrett, James Thomas

Int J Lang Commun Disord· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of treatment for children with developmental speech and language delay/disorder: a meta-analysis.
James Law, Zoe Garrett, Chad Nye

J Speech Lang Hear Res· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Speech and Language Therapy: Its Potential Role in CAMHS.
James Law, Zoe Garrett

Child Adolesc Ment Health· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis